Resistin and
plasminogen activator inhibitor-1 (PAI-1) are
adipokines, which are secreted from adipocytes. Increased plasma
resistin and
PAI-1 levels aggravate
metabolic syndrome through exacerbation of
insulin resistance and induction of chronic
inflammation. However, the relationship between
resistin and
PAI-1 gene expression remains unclear. Previously, we found that
resistin regulates lipid metabolism via
carbohydrate responsive
element-
binding protein (ChREBP) during adipocyte maturation (Ikeda et al., 2013) [6]. In this study, to clarify the relationship between expression of
resistin and
PAI-1,
PAI-1 expression in differentiated 3T3-L1 adipocytes was measured after transfection with anti-
resistin siRNA. We found that
PAI-1 gene expression and secreted
PAI-1 protein were significantly decreased by
resistin knockdown. Furthermore, phosphorylation of Akt, which can inhibit
PAI-1 expression, was accelerated and the activity of
protein phosphatase 2A (PP2A) was suppressed in
resistin knockdown 3T3-L1 adipocytes. In addition, the expression of
glucose transporter type 4, a ChREBP target gene, was reduced and was associated with inhibition of PP2A. The addition of culture medium collected from COS7 cells transfected with a
resistin expression plasmid rescued the suppression of
PAI-1 expression in
resistin knockdown 3T3-L1 adipocytes. Our findings suggest that
resistin regulates
PAI-1 expression in 3T3-L1 adipocytes via Akt phosphorylation.